Clinical characteristics
| Patients undergone TPE (N=95) | ||
|---|---|---|
| Age (years) | 53.3±8.9 | 0.099 |
| Sex, male | 60 (63.2%) | 0.980 |
| Body weight (kg) | 62.0±11.0 | 0.931 |
| Prophylactic use of pheniramine | 82 (86.3%) | 0.647 |
| Indication for TPE | ||
| Desensitization, ABO-i LT | 56 (58.9%) | 0.089 |
| Hyperbilirubinemia | 26 (27.4%) | 0.214 |
| Others | 13 (13.7%) | Reference |
| Type of replacement fluid | 0.691 | |
| FFP only | 21 (22.1%) | |
| Albumin only | 4 (4.2%) | |
| FFP and Albumin | 70 (73.7%) | |
| Amount of FFP (mL/kg) | 34.2±16.4 | 0.085 |
| Amount of albumin (mL/kg) | 24.1±17.1 | 0.077 |
| White blood cell count (×109/L) | 7.1±5.9 | |
| Hemoglobin (g/dL) | 11.1±2.5 | |
| Hematocrit (%) | 32.9±7.5 | |
| Platelet count (×109/L) | 94.7±59.7 | |
| Prothrombin time (sec) | 17.5±4.3 | |
| INR | 1.6±1.3 | |
| Serum albumin (g/dL) | 3.3±0.6 | |
| Serum creatinine (mg/dL) | 1.2±1.0 |
Data are presented as the mean±SD or N (%).